A First Partnership/Licensing Deal-More a Question
Post# of 72440
Cellceutix's finances are in order. Adequate funds are in place-cash on hand, a friendly stock purchase agreement with Aspire Capital Fund, plus the company has access to a healthy shelf registration-to see the company's operations through for at least the next 12 to 18 months. And should the company find a partner, say, for Prurisol (likely first-up), which can generate tens, even hundreds, of millions of dollars, there would be plenty of money to fund many trials.
Just what a company like Cellceutix needs to really blow the lids of its compounds......$ IPIX $ .........shut off all the noise to this strong buy......all imho,tryz